Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial (Q46341489)
scientific article published on 25 September 2008
Language:
(P31) (Q13442814)
(P50) (Q43273739)
(Q44045637)
(Q30223717)
(Q12301832)
(P304) 1385-1393
(P407) (Q1860)
(P433) 9647
(P478) 372
(P577) Thursday, September 25, 2008
(P921) (Q3025883)
(Q269829)
(P1433) (Q939416)
(P1476) "Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial" (language: en)
(P2093) John Fuller
Hans Henrik Parving
Rudy Bilous
Nish Chaturvedi
DIRECT Programme Study Group
(P2860) (Q74432267)
(Q43554872)
(Q27860882)
(Q29617736)
(Q43889672)
(Q37312881)
(Q46853623)
(Q43651902)
(Q66887102)
(Q28144781)
(Q28188182)
(Q29615215)
(Q28188162)
(Q57274347)
(Q46558669)
(Q24244197)
(Q34552302)
(Q44313576)
(Q46641684)
(Q36803964)
(Q31126199)
(Q43829718)
(Q44200597)
(Q57315910)
(Q50946665)
(Q44186257)
(Q33180700)
(Q45009714)
(Q46937192)
(Q37068030)
(Q68931603)
(Q45280910)
(Q35589524)
(Q34292807)
(Q35036623)
(Q73295556)
(Q44512277)
(Q43709066)
(Q46445654)
(Q34502178)
other details
description scientific article published on 25 September 2008

External Links